MDAI (5,6-Methylenedioxy-2-aminoindane) Powder

Description

MDAI is a research chemical belonging to the aminoindane class, known for its distinctive pharmacological profile that emphasizes empathogenic and anxiolytic effects with notably less stimulant activity compared to traditional phenethylamines. Our product is supplied as a fine, free-flowing powder, synthesized under controlled conditions to ensure high chemical purity and batch-to-batch consistency. It is presented as a standard reference material for qualified neuropharmacological research.

Key Attributes & Research Profile:

MDAI is characterized in research literature as a selective serotonin releasing agent (SSRA) with minimal effects on dopamine or norepinephrine systems. This profile suggests a primary action of elevating synaptic serotonin, which correlates with observed effects of pronounced empathy, emotional openness, and mild euphoria without significant cardiovascular stimulation or stimulant-driven anxiety. Its effects are reported to have a gradual onset and extended duration, making it a compound of significant interest for comparative studies of monoamine release agents.

Composition & Handling:

This is a pure compound intended for advanced laboratory analysis. Researchers should utilize appropriate personal protective equipment (PPE) and precise analytical scales for measurement. The powder is stable under standard laboratory storage conditions.

Packaging & Supply:

Packaged in sealed, laboratory-grade plastic vials within static-proof and moisture-proof containment. Available in a wide range of quantities suitable for both initial characterization and ongoing study. All shipments are discreet and comply with regulations regarding the transport of research chemicals for scientific investigation.